News

Pharmerit rebrands to OPEN Health

Highlights from the Patients as Partners Europe Virtual Conference

Patient Engagement in Health Technology Assessment – Report Now Available

Watch the recording of the ISPOR webinar

Market Access in 2021 and Beyond: Reflections on Virtual ISPOR Europe 2020

Just a few musings before ISOQOL from your friendly neighborhood researcher.

Watch the recording of the ISPOR webinar

Join us to discuss HEOR, market access and real-world evidence.

See how the impact of the pandemic has highlighted the use of digital therapeutics.

Talk with our team about how we can support you in the fight against rare diseases.

We are delighted to see that OPEN VIE is a Finalist, not once but twice, in this year's Communiqué Awards!

Today is Juneteenth and we celebrate it every year. But this year isn’t like most years. 

Jeff Anderson appointed as European Lead for OPEN VIE and Pharmerit Europe

We stand behind our diverse, inclusive, and equitable culture. We demand equality, opportunity, and justice for all.

Jordana brings expertise across a wide range of projects in Real-World Evidence

At this most difficult time we wanted to reach out and first express our concern for your safety and health. This is an unprecedented situation in our lifetimes where we should work together and support each other to overcome this challenge.

Meet two of OPEN Health’s practices—Peloton Advantage and Pharmerit International—at booth #4 at MAPS Global 2020, the World's Largest Assembly of Medical Affairs Professionals, to be held in Miami, Florida from March 8 – 11, 2020.

Join Pharmerit and OPEN Health on our journey in 2020

Patients increasingly want to be more involved in their healthcare, decisions about it and research towards its improvement, and there are some shining examples of patients moving front and centre to lead discussions.

Dr. Patti Peeples, CEO of HealthEconomics.com, sat down with Walter Bouwmeester, Real-World Evidence and Data Analytics Lead in Europe, to discuss the use of data analytics to support multidimensional health economics and outcomes research (HEOR) in Europe.

OPEN Health has today announced the integration of Pharmerit International, a global leader in health economics and outcomes research (HEOR), into its group of companies.

Pharmerit International (Pharmerit), a leading provider of health economics and outcomes research (HEOR) and market access research services, has announced the opening of a new office in Oxford, UK.

Pharmerit International (Pharmerit), a leading health economics and outcomes research (HEOR) consultancy, is expanding its Asian presence. The expansion includes the growth of the Shanghai, China, office as well as establishment of an office in Mumbai, India.

This holiday season, we take a moment to thank our sponsors for the partnerships we have formed in demonstrating value together.